Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Ibuprofen recalled?

Yes — there is an active recall. 15 ongoing FDA recalls mention Ibuprofen (68 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Ibuprofen. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Ibuprofen recalls on record

none so far in 2026; 68 on record, newest first
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-9 D-0299-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-8 D-0298-2020
Class II · Moderate risk

Infants' Ibuprofen

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Terminated Wrong potency / content Tris Pharma Inc. NDC 50428-1252-4 D-0495-2019
Class II · Moderate risk

infants* IBUPROFEN

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Terminated Wrong potency / content Tris Pharma Inc. NDC 49035-125-24 D-0494-2019
Class II · Moderate risk

Infants' Ibuprofen

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Terminated Wrong potency / content Tris Pharma Inc. NDC 59779-925-23 D-0493-2019
Class II · Moderate risk

Infants' Ibuprofen

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Terminated Wrong potency / content Tris Pharma Inc. NDC 55319-250-23 D-0336-2019
Class II · Moderate risk

infants* IBUPROFEN

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Terminated Wrong potency / content Tris Pharma Inc. NDC 49035-125-23 D-0335-2019
Class II · Moderate risk

Ibuprofen Caplets USP 200 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 53943-292-15 D-0695-2018
Class II · Moderate risk

Ibuprofen Caplets USP 200 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 49483-600-05 D-0694-2018
Class II · Moderate risk

Ibuprofen Tablets USP 800 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 42582-113-10 D-0693-2018
Class II · Moderate risk

Ibuprofen Tablets USP 800 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 49483-604-01 D-0692-2018
Class II · Moderate risk

Ibuprofen Tablets USP 600 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 42582-112-01 D-0691-2018
Class II · Moderate risk

Ibuprofen Tablets USP 600 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 42582-112-10 D-0690-2018
Class II · Moderate risk

Ibuprofen Tablets USP 600 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 49483-603-01 D-0689-2018
Class II · Moderate risk

Ibuprofen Tablets USP 400 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 42582-111-18 D-0688-2018
Class II · Moderate risk

Ibuprofen Tablets USP 400 mg

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 49483-602-01 D-0687-2018
Class II · Moderate risk

Ibuprofen Tablets

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 53943-291-15 D-0686-2018
Class II · Moderate risk

Ibuprofen Tablets

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Terminated cGMP deviation Time-Cap Laboratories, Inc. NDC 49483-601-05 D-0685-2018